
Agnieszka Boesen
Examiner (ID: 10144, Phone: (571)272-8035 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1672, 1648 |
| Total Applications | 1050 |
| Issued Applications | 614 |
| Pending Applications | 117 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7323456
[patent_doc_number] => 20040137431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Target sequences for the detection of the west nile virus'
[patent_app_type] => new
[patent_app_number] => 10/700118
[patent_app_country] => US
[patent_app_date] => 2003-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 3105
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20040137431.pdf
[firstpage_image] =>[orig_patent_app_number] => 10700118
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/700118 | Target sequences for the detection of the west nile virus | Nov 2, 2003 | Abandoned |
Array
(
[id] => 5776345
[patent_doc_number] => 20060104985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Dengue virus infection inhibitor'
[patent_app_type] => utility
[patent_app_number] => 10/532211
[patent_app_country] => US
[patent_app_date] => 2003-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9688
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20060104985.pdf
[firstpage_image] =>[orig_patent_app_number] => 10532211
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/532211 | Dengue virus infection inhibitor | Oct 21, 2003 | Abandoned |
Array
(
[id] => 7280393
[patent_doc_number] => 20040062770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Modulators of fgl2 prothrombinase'
[patent_app_type] => new
[patent_app_number] => 10/688962
[patent_app_country] => US
[patent_app_date] => 2003-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13035
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20040062770.pdf
[firstpage_image] =>[orig_patent_app_number] => 10688962
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/688962 | Modulators of fgl2 prothrombinase | Oct 20, 2003 | Abandoned |
Array
(
[id] => 5747805
[patent_doc_number] => 20060110736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Hiv vaccine formulations'
[patent_app_type] => utility
[patent_app_number] => 10/530543
[patent_app_country] => US
[patent_app_date] => 2003-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22569
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20060110736.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530543
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530543 | Hiv vaccine formulations | Oct 6, 2003 | Abandoned |
Array
(
[id] => 7304355
[patent_doc_number] => 20040115752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Method for testing samples containing prion protein for the possible presence of the prpsc form'
[patent_app_type] => new
[patent_app_number] => 10/474107
[patent_app_country] => US
[patent_app_date] => 2003-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2074
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20040115752.pdf
[firstpage_image] =>[orig_patent_app_number] => 10474107
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/474107 | Method for testing samples containing prion protein for the possible presence of the prpsc form | Oct 6, 2003 | Abandoned |
Array
(
[id] => 7280719
[patent_doc_number] => 20040063096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Oligonucleotides and method for characterizing and detecting genogroup II type small round structured virus'
[patent_app_type] => new
[patent_app_number] => 10/678124
[patent_app_country] => US
[patent_app_date] => 2003-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7256
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063096.pdf
[firstpage_image] =>[orig_patent_app_number] => 10678124
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/678124 | Oligonucleotides and method for characterizing and detecting genogroup II type small round structured virus | Oct 5, 2003 | Abandoned |
Array
(
[id] => 7208985
[patent_doc_number] => 20040087774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'TRAF inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/679014
[patent_app_country] => US
[patent_app_date] => 2003-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13570
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20040087774.pdf
[firstpage_image] =>[orig_patent_app_number] => 10679014
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/679014 | TRAF inhibitors | Oct 2, 2003 | Abandoned |
Array
(
[id] => 7261514
[patent_doc_number] => 20040241191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Recombinant vaccine against West Nile virus'
[patent_app_type] => new
[patent_app_number] => 10/676502
[patent_app_country] => US
[patent_app_date] => 2003-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14221
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241191.pdf
[firstpage_image] =>[orig_patent_app_number] => 10676502
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/676502 | Recombinant vaccine against West Nile virus | Sep 29, 2003 | Abandoned |
Array
(
[id] => 7117301
[patent_doc_number] => 20050070602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Method of modulating immune response by administration of immuno-activation agent'
[patent_app_type] => utility
[patent_app_number] => 10/673426
[patent_app_country] => US
[patent_app_date] => 2003-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7670
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20050070602.pdf
[firstpage_image] =>[orig_patent_app_number] => 10673426
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/673426 | Method of modulating immune response by administration of immuno-activation agent | Sep 29, 2003 | Abandoned |
Array
(
[id] => 7349423
[patent_doc_number] => 20040047882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Adjuvant for vaccines'
[patent_app_type] => new
[patent_app_number] => 10/221941
[patent_app_country] => US
[patent_app_date] => 2003-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2799
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20040047882.pdf
[firstpage_image] =>[orig_patent_app_number] => 10221941
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/221941 | Adjuvant for vaccines | Sep 28, 2003 | Abandoned |
Array
(
[id] => 6977401
[patent_doc_number] => 20050287117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Vaccine enhancing the protective immunity to hepatitis c virus using plasmid dna and recombinant adenovirus'
[patent_app_type] => utility
[patent_app_number] => 10/528644
[patent_app_country] => US
[patent_app_date] => 2003-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 20219
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287117.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528644
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528644 | Vaccine enhancing the protective immunity to hepatitis c virus using plasmid DNA and recombinant adenovirus | Sep 23, 2003 | Issued |
Array
(
[id] => 292483
[patent_doc_number] => 07544775
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-09
[patent_title] => 'Systems for expressing toxic proteins, vectors and method of producing toxic proteins'
[patent_app_type] => utility
[patent_app_number] => 10/528344
[patent_app_country] => US
[patent_app_date] => 2003-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 8
[patent_no_of_words] => 9805
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/544/07544775.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528344
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528344 | Systems for expressing toxic proteins, vectors and method of producing toxic proteins | Sep 18, 2003 | Issued |
Array
(
[id] => 7325052
[patent_doc_number] => 20040138119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis'
[patent_app_type] => new
[patent_app_number] => 10/665975
[patent_app_country] => US
[patent_app_date] => 2003-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22969
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20040138119.pdf
[firstpage_image] =>[orig_patent_app_number] => 10665975
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/665975 | Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis | Sep 17, 2003 | Abandoned |
Array
(
[id] => 4547798
[patent_doc_number] => 07820181
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-26
[patent_title] => 'Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens'
[patent_app_type] => utility
[patent_app_number] => 10/667141
[patent_app_country] => US
[patent_app_date] => 2003-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 60957
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/820/07820181.pdf
[firstpage_image] =>[orig_patent_app_number] => 10667141
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/667141 | Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens | Sep 17, 2003 | Issued |
Array
(
[id] => 7230706
[patent_doc_number] => 20050079171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Pseudomonas exotoxin A-like chimeric immunogens for eliciting a secretory IgA-mediated immune response'
[patent_app_type] => utility
[patent_app_number] => 10/659036
[patent_app_country] => US
[patent_app_date] => 2003-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 25139
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20050079171.pdf
[firstpage_image] =>[orig_patent_app_number] => 10659036
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/659036 | Pseudomonas exotoxin A-like chimeric immunogens for eliciting a secretory IgA-mediated immune response | Sep 8, 2003 | Abandoned |
Array
(
[id] => 7460333
[patent_doc_number] => 20040052812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Heat shock protein-based antiviral vaccines'
[patent_app_type] => new
[patent_app_number] => 10/258146
[patent_app_country] => US
[patent_app_date] => 2003-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11876
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20040052812.pdf
[firstpage_image] =>[orig_patent_app_number] => 10258146
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/258146 | Heat shock protein-based antiviral vaccines | Sep 4, 2003 | Abandoned |
Array
(
[id] => 448261
[patent_doc_number] => 07250251
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-31
[patent_title] => 'Virion-based fusion assay'
[patent_app_type] => utility
[patent_app_number] => 10/656803
[patent_app_country] => US
[patent_app_date] => 2003-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 15859
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/250/07250251.pdf
[firstpage_image] =>[orig_patent_app_number] => 10656803
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/656803 | Virion-based fusion assay | Sep 3, 2003 | Issued |
Array
(
[id] => 7229198
[patent_doc_number] => 20040073259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Treatment of patients infected by disease causing organisms or biological warfare agents using hyperthermia'
[patent_app_type] => new
[patent_app_number] => 10/649544
[patent_app_country] => US
[patent_app_date] => 2003-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11046
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20040073259.pdf
[firstpage_image] =>[orig_patent_app_number] => 10649544
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/649544 | Treatment of patients infected by disease causing organisms or biological warfare agents using hyperthermia | Aug 25, 2003 | Abandoned |
Array
(
[id] => 5726876
[patent_doc_number] => 20060057636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins'
[patent_app_type] => utility
[patent_app_number] => 10/525533
[patent_app_country] => US
[patent_app_date] => 2003-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18634
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20060057636.pdf
[firstpage_image] =>[orig_patent_app_number] => 10525533
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/525533 | Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins | Aug 24, 2003 | Abandoned |
Array
(
[id] => 7246456
[patent_doc_number] => 20050272029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Hepatitis c viral-like particle purification'
[patent_app_type] => utility
[patent_app_number] => 10/524443
[patent_app_country] => US
[patent_app_date] => 2003-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 18814
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272029.pdf
[firstpage_image] =>[orig_patent_app_number] => 10524443
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/524443 | Hepatitis c viral-like particle purification | Aug 17, 2003 | Abandoned |